Pain Management - Leadership Responsibility for Providing Access to Prescription Drug Monitoring Program (PDMP) databases - LD.04.03.13 EP 6

Please explain what is meant by the requirement that "The organization facilitates practitioner and pharmacist access to the Prescription Drug Monitoring Program (PDMP) databases". Does this mean that the organization is required to access the PDMP for every patient receiving opioids?

Any examples are for illustrative purposes only.

Facilitating access to the Prescription Drug Monitoring Program (PDMP) means that leadership has implemented systems and processes that support both ease of access and consistent access to the PDMP when required.  Examples may include:
• Shortcuts on designated computer desktops to the PDMP database
• Links from the organization's intranet site and/or electronic health record (EHR)
• Staff and practitioner education that includes access to and when the PDMP is to be queried
• Demonstration/return demonstration
• Periodic monitoring of compliance as defined 
• Periodic refreshers with staff, as defined by the organization
• Creating prompts in an electronic medical record (when state law requires accessing before hospital discharge).

Each organization determines who is responsible for accessing the PDMP. This may vary based on different patient care settings. Refer to the state PDMP legislation or regulations which define criteria for requesting/checking PDMP data. During survey, compliance with accessing the PDMP may be evaluated during tracer activities, interviews with staff, practitioners, pharmacists, etc.

The requirement does NOT apply to patients receiving short term opioid medications DURING the hospital encounter, unless required by state law (for example, opioids administered for a day or two following a surgical or invasive procedure).  During survey, compliance with accessing the PDMP may be evaluated during tracer activities, interviews with staff, practitioners, pharmacists, etc.

NOTE 1: This element of performance is only applicable in states that have a fully functioning Prescription Drug Monitoring Program (PDMP).
NOTE 2: This requirement is not applicable to all settings in the ambulatory care program. Refer to an applicability grid in the E-dition or standards manual for details.


Resources:
R3 Report: Pain assessment and management standards for Ambulatory Care
R3 Report: Pain assessment and management standards for Office-based Surgery
Sentinel Event Alert Issue 49: Safe use of opioids in hospitals
 

 
Last updated on May 04, 2020
Manual: Ambulatory
Chapter: Leadership LD

If no, please comment on how we could improve this response.

If you have additional standards-related questions regarding this topic, please use the Standards Online Submission Form